VADIS Trial: Phase II Trial of Nelipepimut-S Peptide Vaccine in Women With DCIS of the Breast
Phase of Trial: Phase II
Latest Information Update: 14 Dec 2017
At a glance
- Drugs Nelipepimut-S (Primary) ; Sargramostim
- Indications Breast cancer
- Focus Pharmacodynamics
- Acronyms VADIS
- 10 Jun 2017 Biomarkers information updated
- 30 Nov 2016 According to a Galena Biopharma media release, trial design will be presented at the upcoming San Antonio Breast Cancer Symposium.
- 30 Nov 2016 According to a Galena Biopharma media release, this trial is expected to initiate by the end of the year.